Ceiling prices for negotiation would have reduced Medicare prescription drug spending by ~5 percent if implemented from 2018 to 2020
8.4 percent of adults took sleep meds every day or most days in last 30 days; women were more likely to take sleep meds than men
Proportion of youth aged 19 years and younger dispensed buprenorphine decreased 45 percent from 2015 to 2020
Proportion of overdose deaths did not increase in association with actions taken to ease access to buprenorphine
Lower use of psychotropic, antihypertensive, and asthma medications observed; association attenuated by body mass index
Letters highlighting mandate to check PMP before prescribing can increase PMP search rates and PMP account-holding rates
Period prevalence of all antipsychotic prescriptions increased 3.3 percent per year from 2000 to 2019
Improvement in self-reported antiretroviral therapy adherence and decrease in viral load seen with intervention
Controversy over Aduhelm stretches back to its June 2021 approval by the U.S. Food and Drug Administration
Magnitude of association for finasteride and dutasteride with dementia decreased over time and became nonsignificant